Sortiert nach PI

Publikationen - sortiert nach Principle Investigator

• Han L, Kasper S, Kranz G (2026) Hindrance to precision psychiatry: more sex-specific investigations needed World J Biol Psychiatry, 27 : 89-90
  | Weblink |
• Serretti A, Souery D, Kasper S, Zohar J, Montgomery S, Ferentinos P, Rujescu D, Ferri R, Fanelli G, Fabbri C, Zanardi R, Benedetti F, Baune B, Mendlewicz J (2026) Schizophrenia Genetics Modulates Clinical Depressive Features Am J Med Genet B Neuropsychiatr Genet, 201 : 180-193
  | Weblink |
• Eckert D, Kasper S (2026) Pharmacological augmentation in treatment-resistant depression: a neurobiologically informed, practical decision guide for treatment choice with lithium, quetiapine, or esketamine Int J Psychiatry Clin Pract,
  | Weblink |
• Wegener G, Lerer B, Frazer A, Grace A, Ikeda K, Gobbi G, Young A, Zohar J, Blier P, Kasper S, Krystal J, Yamawaki S, Philips A, Möller H, Belmaker R, Atwoli L, Nutt D, Harvey B, Seedat S, Berk M, Emsley R (2026) In memoriam: Professor Dan J. Stein (1962-2025) — a global pioneer with an African heart Int J Neuropsychopharmacol, 29 : pyaf079
  | Weblink |
• Eckert D, Kasper S (2026) Beyond first-line antidepressants: lithium, quetiapine, or esketamine? Integrating meta-analyses and preliminary head-to-head evidence World J Biol Psychiatry, 27 : 200-211
  | Weblink |
• Olgiati P, Luca M, Luca A, Messina A, Souery D, Kasper S, Zohar J, Montgomery S, Ferentinos P, Rujescu D, Zanardi R, Ferri R, Mendlewicz J, Serretti A (2026) Prognostic implications of social anxiety comorbidity in major depressive disorder. Evidence from three large samples with adult and older patients J Affect Disord, 402: 121308
  | Weblink |
• Luca M, Luca A, Barlati S, Buson L, Menesello V, Magistrali A, Silva R, Perusi G, Nibbio G, Bignotti S, Tura G, Ferri R, Gennarelli M, Vita A, Souery D, Kasper S, Zohar J, Montgomery S, Ferentinos P, Rujescu D, Zanardi R, Mendlewicz J, Minelli A, Serretti A, Minelli A, Gennarelli M, Menesello V, Lana B, Galbiati C, Giacopuzzi E, Vitali E, Perusi G, Buson L, Scaglia M, Dattilo V, Vita A, Barlati S, Muscarella A, Baglioni A, Nibbio G, Pinton I, Bertoni L, Necchini N, Paolini S, Umbertino U, Magistrali A, Magri C, Meattini M, Silva R, Martini P, Cobelli C, Tura G, Bignotti S, Spina E (2026) Agitation and anxiety features define a more severe phenotype in unipolar depression Psychiat Res, 357: 116928
  | Weblink |
• Müller T, Künzi A, Heitlinger E, Krämer B, von Känel R, Hättenschwiler J, Hilpert M, Imboden C, Holsboer-Trachsler E, Hatzinger M, Kasper S, Bandelow B, Seifritz E (2026) Comparative efficacy and acceptability of anxiolytic drugs for the treatment of anxiety disorders: a systematic review and network meta-analysis Eur Arch Psychiatry Clin Neurosci,
  | Weblink |
• Silberbauer L, Eggerstorfer B, Michenthaler P, Reichel S, Stimpfl T, Vanicek T, Naderi-Heiden A, Kasper S, Lanzenberger R, Gryglewski G (2026) Oral ketamine for the treatment of major depressive and bipolar disorder, a randomized controlled trial and meta-analysis J Affect Disord, 394: 120466
  | Weblink |

• Goldberg J, Swartz H, McIntyre R, Mago R, Malhi G, Jha M, Berk M, Kasper S, Freeman M, Gitlin M, Sajatovic M, Ostacher M, Citrome L, Iosifescu D, Perlis R, Furukawa T, Vieta E, Thase M, Young A, Tohen M, Nierenberg A, Macaluso M, Shelton R, Correll C, Aaronson S, Rosenblat J, Gorwood P, Khan A, Kupka R, Cohen L, Mitchell P, Frye M, Sanacora G, Kane J, Rubio-Lorente J, Goodman D, Zohar J, Davis L, Gupta S, Steingard S, Zarate C, Clayton A (2026) The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus Br J Psychiatry,
  | Weblink |
• Himmerich H, Keeler J, King J, Ehrlich S, Kaufmann L, Bulik C, Cohen-Woods S, Wade T, Steiger H, Booij L, Monteleone P, Cascino G, Monteleone A, Cuntz U, Voderholzer U, Tessema S, Lewis Y, Sjögren M, Hebebrand J, Seitz J, Tyszkiewicz-Nwafor M, Karpenko O, Mutwalli H, Fetissov S, Mack I, Dhopatkar N, Mörkl S, Kan C, Uribe M, Yoshiuchi K, Abuobeid N, Kapogiannis D, Stein D, Bektas S, Müller D, Gorwood P, Duriez P, Montcel C, Paszyńska E, McElroy S, Wranik W, Fernandez-Aranda F, Mehler P, Papežová H, Roubalová R, Procházková P, Morris R, Lewczuk P, Hiemke C, Berk M, Karwautz A, Treasure J, Kasper S (2026) World Federation of Societies of Biological Psychiatry (WFSBP) consensus statement on candidate biomarkers for anorexia nervosa World J Biol Psychiatry, 27: 257-348
  | Weblink |
• Mairinger M, Godbersen G, Kasper S (2026) Neuropsychiatric manifestations of primary hyperparathyroidism Wien. Klin. Wochenschr., 138 (7-8): 232-240
  | Weblink |
• Young A, Fagiolini A, Agüera-Ortiz L, Siwek M, Kasper S (2026) Expert consensus on the use of trazodone in patients with major depressive disorder: results from a European Delphi panel Eur Psychiatry, 69 : e36
  | Weblink |

• Kasper S (2025) Siegfried Kasper: „Es ist wichtig, klinische Erkenntnisse in die Grundlagenforschung einfließen zu lassen“. Jatros Neurologie & Psychiatrie , 5: 6
• Baldinger-Melich P, Spies M, Bozic I, Kasper S, Rujescu D, Frey R (2025) Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy Wien. Klin. Wochenschr., 137 : 134-147
• Kasper S (2025) Angst und Depression: hohe Komorbiditätsrate Spectrum Psychiatrie, 4: 36-37
• Kasper S (2025) Über den Wert von Metaanalysen in der ärztlichen Praxis Journal für Neurologie, Neurochirurgie und Psychiatrie, 26: 63-64
• Neibert V, Kloimstein P, Kasper S, Bartova L (2025) Phyto-Psychopharmakotherapie – Effektive und evidenzbasierte Behandlung von Angsterkrankungen, Depression und assoziierten Beschwerden Journal für Neurologie, Neurochirurgie und Psychiatrie, 26: 39-47
• Abondio P, Fanelli G, Baldini V, Bacalini M, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Serretti A, Monteleone A, Grassi L, Atti A, Menchetti M, Fabbri C, De Ronchi D (2025) Polygenic predisposition to transdiagnostic symptom dimensions and treatment outcomes across psychiatric disorders Prog in Neuropsychopharmaco & Biolog. Psychiatry , 142: 111512
• Baldinger-Melich P, Spies M, Bozic I, Kasper S, Rujescu D, Frey R (2025) Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy Wien. Klin. Wochenschr., 137 (5-6): 134-147
• Serretti A, Souery D, Kasper S, Bartova L, Zohar J, Montgomery S, Ferentinos P, Rujescu D, Ferri R, Fanelli G, Zanardi R, Benedetti F, Baune B, Mendlewicz J (2025) Polygenic liability to C-reactive protein defines immunometabolic depression phenotypes and influences antidepressant therapeutic outcomes Genomic Psychiatry , 1 (5): 30-35
  | Weblink |
• Kasper S (2025) Siegfried Kasper: The importance of back-translation of clinical findings to basic science Brain Medicine, 1 (5): 30-33
  | Weblink |
• Schlosser G, Murgaš M, Godbersen G, Reichel S, Silberbauer L, Nics L, Winkler D, Stimpfl T, Hacker M, Kasper S, Rujescu D, Lanzenberger R, Spies M (2025) Human in vivo assessment of ketamine binding of the serotonin transporter—follow up at a higher dose Front Neurosci, 19: 651016
  | Weblink |
• Serretti A, Kasper S, Bartova L, Zohar J, Souery D, Montgomery S, Ferentinos P, Rujescu D, Kautzky A, Attanasio F, Zanardi R, Fabbri C, Baune B, Ferri R, Mendlewicz J (2025) Clinical predictors of treatment resistant depression Eur Neuropsychopharmacol, 98: 26-34
  | Weblink |
• White I, Luca A, Luca M, Bartova L, Kasper S, Zohar J, Souery D, Montgomery S, Ferentinos P, Rujescu D, Mendlewicz J, Zanardi R, Ferri R, Lanza G, Rodolico A, Signorelli M, Serretti A (2025) The impact of depression on functioning: Relation to medication response and other predictors Psychiat Res, 351: 116599
  | Weblink |
• Luca A, Luca M, Kasper S, Zohar J, Souery D, Montgomery S, Ferentinos P, Rujescu D, Mendlewicz J, Zanardi R, Ferri R, Lanuzza B, Pecorino B, Baune B, Fanelli G, Fabbri C, Serretti A (2025) Mild motor signs and depression: more than just medication side effects? Eur Arch Psychiatry Clin Neurosci, 276: 451-457
  | Weblink |
• Kasper S, Incalzi R, Bozzali M, Morgado P, Siwek M (2025) Managing depression in the elderly: real-world clinical considerations and perspectives Int Clin Psychopharmacol, 40: 339-352
  | Weblink |
• Kautzky A, Bartova L, Dold M, Souery D, Montgomery S, Zohar J, Mendlewicz J, Fabbri C, Serretti A, Tretiakov E, Rujescu D, Harkany T, Kasper S (2025) Symptom networks in major depressive disorder and treatment response: special focus on TRD Eur Psychiatry, 68 (1): e61
  | Weblink |
• Murgaš M, Milz C, Stöhrmann P, Unterholzner J, Nics L, Kranz G, Hahn A, Hacker M, Kasper S, Lanzenberger R, Godbersen G (2025) In vivo serotonin 1A receptor distribution in treatment-resistant depression Transl Psychiat, 15 : 186
  | Weblink |
• Oliva V, Possidente C, Fanelli G, Domschke K, Minelli A, Gennarelli M, Martini P, Bortolomasi M, Squassina A, Pisanu C, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Baune B, Vieta E, Serretti A, Fabbri C (2025) Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis Eur Neuropsychopharmacol, 96: 17-27
  | Weblink |
• Luca M, Luca A, Messina A, Bartova L, Kasper S, Zohar J, Souery D, Montgomery S, Ferentinos P, Rujescu D, Mendlewicz J, Zanardi R, Ferri R, Lanuzza B, Benedetti F, Pecorino B, Baune B, Fanelli G, Fabbri C, Serretti A (2025) Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sex J Affect Disord, 375: 249-255
  | Weblink |
• Calabrò M, Fabbri C, Serretti A, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Colombo C, Zanardi R, De Ronchi D, Crisafulli C (2025) A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors Psychiat Gen, 35 (2): 17-25
  | Weblink |
• Spies M, Kasper S, Frey R, Baldinger-Melich P (2025) KET or ECT for treatment-resistant depression? Int J Psychiatry Clin Pract, 28: 235-237
  | Weblink |
• Kasper S, Incalzi RA, Bozzali M, Morgado P, Siwek M (2025) Managing Depression in the Elderly: Real-World Clinical Considerations and Perspectives on the Use of Trazodone. International Clinical Psychopharmacology Int Clin Psychopharmacol,
  | Weblink |
• Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Electronic address: andrew.mcintosh@ed.ac.uk; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium including Kasper S (2025) Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies Cell, 188: 640–652
  | Weblink |
• Olgiati P, Kasper S, Zohar J, Souery D, Montgomery S, Ferentinos P, Rujescu D, Zanardi R, Fugger G, Ferri R, Tripodi M, Baune B, Fabbri C, Mendlewicz J, Serretti A (2025) Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues J Affect Disord, 369: 1021-1030
  | Weblink |

• Vanicek T, Höflich A, Unterholzner J, Rujescu D, Kasper S (2025) ADHS im Erwachsenenalter. Diagnostik, Komorbiditäten und medikamentöse Therapie. Konsensus-Statement Jatros Neurologie & Psychiatrie , Sonderheft
• Rujescu D, Stögmann E, Winkler D, Kasper S (2025) Demenzerkrankungen, Konsensus-Statement Jatros Neurologie & Psychiatrie , Sonderheft